POU2F1 and acute myeloid leukemia: For tumors of the hematopoietic system, the pro-oncogenic functions of Oct-1 have been described for Hodgkin’s lymphoma, thymus lymphoma, diffuse large B-lymphoma, and acute myeloid leukemia [7–9].